03/15/2022
Participants needed in a phase 2 clinical trial testing a new investigational medication for ongoing celiac disease symptoms. NO GLUTEN CHALLENGE.
This trial is testing the investigational medication PRV-015 in people with celiac disease who still experience symptoms despite being on a gluten-free diet.
Combined with a gluten-free diet, PRV-015 aims to reduce celiac symptoms and intestinal inflammation caused by accidental gluten exposure.
Learn more at
https://relianceresearch.org/proactive-celiac-disease-study/
See if you qualify at
survey.proactiveceliac.com/r/REFCDF
Use referral code: REFCDF